ArticleClinical and experimental pediatrics2024
Effectiveness of Helmet therapy for infants with moderate to severe positional plagiocephaly.
Article in Clinical and experimental pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Impact of Age on Success of 3D-Printed Cranial Remolding Orthoses for Deformational Head Shapes.Journal of clinical medicine · 2026Article
- SoftSpot3D: prospective study of mobile 3D reconstruction for infants' cranial conditions.Journal of medical imaging (Bellingham, Wash.) · 2026Article
- A Review of Cranial Remolding Orthosis Treatment for Babies with Combinational Deformational Plagiocephaly with Brachycephaly and Development of a New Classification Scale.Children (Basel, Switzerland) · 2026Article
- Helmet Therapy for Deformational Plagiocephaly: Clinical Outcomes and Considerations.Children (Basel, Switzerland) · 2025Article
- Comparative analysis of goal attainment for helmet therapy versus conservative management for positional plagiocephaly in infants.Clinical and experimental pediatrics · 2025Article
- A 10-Year Review of the Efficacy of Cranial Remolding Orthosis Treatment and Factors That Influence Outcomes for Infants with Isolated Deformational Plagiocephaly.Children (Basel, Switzerland) · 2025Article
- Natural Progression of Cranial Shape Following Helmet Therapy for Deformational Plagiocephaly.Journal of clinical medicine · 2025Article
- 3D-printed cranial helmet therapy for the treatment of deformational plagiocephaly.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of helmet treatment for positional plagiocephaly has increased recently; however, its effect is unknown in Korea. PURPOSE: This study aimed to investigate the effectiveness of helmet therapy and identify its influencing factors.
methodsNinety pediatric patients diagnosed with moderate to severe positional plagiocephaly received helmet therapy. Severity of moderate to severe positional plagiocephaly was defined as cranial vault asymmetry (CVA) >10 mm or CVA index (CVAI) >6%. Patients were categorized by age, severity, and daily helmet wear. Multiple regression analysis controlled for factors like sex and prematurity. Treatment success was assessed by comparing pre/post-helmet theray CVA and CVAI, considering normalization or decrease to mild plagiocephaly (CVA ≤10 mm or CVAI ≤6%).
resultsA total of 90 participants were enrolled (mean age, 5.6±1.6 months; male, 53 [58.9%]). The mean helmet therapy duration was 6.4±2.7 months, while the mean daily wear time was 18.4±2.7 hours. Among the 90 patients, 66 (73.3%) had moderate disease and 24 (26.7%) had severe disease. The mean CVA and CVAI decreased by 6.3±2.7 mm and 4.3%±1.8% after versus before treatment (P<0.001). Treatment was successful in 76 infants (84.4%). The most effective changes in CVA and CVAI were noted in those who began treatment before 9 months of age (6.2±2.5 mm and 5.0%±1.9%, P<0.001), had high compliance (6.2±2.4 mm and 4.9%±1.9%, P<0.001), and had high severity (8.0±2.3 mm and 6.6%±1.7%, P<0.001).
conclusionStarting helmet treatment before 9 months and wearing it over 15 hours daily yielded better outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.